Amanote Research

Amanote Research

  • Register
  • Sign In

Prognostic Implications of Claudin 4 and Rock 1 in Triple Negative Breast Cancer

Journal of Cancer Treatment and Research

doi 10.11648/j.jctr.20170506.13

Full Text

Abstract

Available in

Date

January 1, 2017

Authors

Shimaa Ahmed

Publisher

Science Publishing Group


Related search

Exploring Specific Prognostic Biomarkers in Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Neutrophil:Lymphocyte Ratios Have Prognostic Value in Triple-Negative Breast Cancer

Journal of Nihon University Medical Association
2017English

Identification of New Prognostic Biomarkers for Triple Negative Breast Cancer

English

TLR5: A Prognostic and Monitoring Indicator for Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Prognostic Role of Family History in Patients With Triple Negative Breast Cancer

Turk Onkoloji Dergisi
Oncology
2020English

Triple-Negative Breast Cancer

2018English

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer

Frontiers in Medicine
Medicine
2019English

Upregulation of Claudin-4, CAIX and GLUT-1 in Distant Breast Cancer Metastases

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy